beat Wall Street's first-quarter sales forecasts Thursday on the back of its Covid treatment, Veklury. Gilead stock jumped in late trades.
However, two out of three of Gilead's cancer drugs — cell therapy Tecartus and antibody drug conjugate Trodelvy — lagged expectations. Tecartus treats forms of lymphoma and leukemia, while Trodelvy is a breast and bladder cancer treatment.…

#veklury#gilead#trodelvy#yescarta#andrewdickinson#ibd#cymabay#danieloday